ATE128128T1 - Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one. - Google Patents

Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.

Info

Publication number
ATE128128T1
ATE128128T1 AT91910593T AT91910593T ATE128128T1 AT E128128 T1 ATE128128 T1 AT E128128T1 AT 91910593 T AT91910593 T AT 91910593T AT 91910593 T AT91910593 T AT 91910593T AT E128128 T1 ATE128128 T1 AT E128128T1
Authority
AT
Austria
Prior art keywords
antiatherosclerotic
antithrbotic
pyran
phenyl
amino
Prior art date
Application number
AT91910593T
Other languages
English (en)
Inventor
Joel Morris
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE128128T1 publication Critical patent/ATE128128T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
AT91910593T 1990-06-29 1991-06-03 Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one. ATE128128T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54593590A 1990-06-29 1990-06-29

Publications (1)

Publication Number Publication Date
ATE128128T1 true ATE128128T1 (de) 1995-10-15

Family

ID=24178137

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91910593T ATE128128T1 (de) 1990-06-29 1991-06-03 Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.

Country Status (11)

Country Link
EP (1) EP0489877B1 (de)
JP (1) JPH05501886A (de)
KR (1) KR920702353A (de)
AT (1) ATE128128T1 (de)
AU (1) AU630822B2 (de)
CA (1) CA2064796A1 (de)
DE (1) DE69113221T2 (de)
DK (1) DK0489877T3 (de)
ES (1) ES2079068T3 (de)
GR (1) GR3018304T3 (de)
WO (1) WO1992000290A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
TW587079B (en) * 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives
CA2405561A1 (en) * 2000-04-05 2001-10-18 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
GB0119865D0 (en) * 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB2405870B (en) * 2001-08-14 2005-07-06 Cancer Rec Tech Ltd DNA-PK inhibitors
GB0204350D0 (en) * 2002-02-25 2002-04-10 Kudos Pharm Ltd ATM inhibitors
US7049313B2 (en) 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
EP1485377B9 (de) * 2002-02-25 2010-10-06 Kudos Pharmaceuticals Limited Als atm-inhibitoren geeignete pyranone
GB2420781B (en) 2003-08-13 2008-07-09 Kudos Pharm Ltd Aminopyrones and their use as ATM inhibitors
US20070238731A1 (en) 2004-09-20 2007-10-11 Kudos Pharmaceuticals Limited Dna-Pk Inhibitors
WO2006085067A1 (en) 2005-02-09 2006-08-17 Kudos Pharmaceuticals Limited Atm inhibitors
AR054438A1 (es) 2005-04-15 2007-06-27 Kudos Pharm Ltd Inhibidores de adn -pk
EP2155194B1 (de) 2007-04-06 2015-01-21 Neurocrine Biosciences, Inc. Antagonisten des gonadotropin-releasing hormone rezeptors und damit in zusammenhang stehende verfahren
US8263588B2 (en) 2007-04-06 2012-09-11 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
CN102731456B (zh) * 2011-04-01 2014-07-09 华中科技大学 一种抗肿瘤化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2452487A1 (fr) * 1979-03-28 1980-10-24 Rhone Poulenc Agrochimie Nouveaux derives de la phenyl-2-pyrone-4 et leur utilisation comme fongicides
EP0459983A1 (de) * 1988-12-21 1991-12-11 PHARMACIA & UPJOHN COMPANY Antiatherosklerotische und antithrombotische 1-benzopyran-4-one und 2-amino-1,3-benzoxazin-4-one

Also Published As

Publication number Publication date
EP0489877B1 (de) 1995-09-20
ES2079068T3 (es) 1996-01-01
GR3018304T3 (en) 1996-03-31
EP0489877A1 (de) 1992-06-17
DK0489877T3 (da) 1996-02-05
JPH05501886A (ja) 1993-04-08
AU630822B2 (en) 1992-11-05
WO1992000290A1 (en) 1992-01-09
KR920702353A (ko) 1992-09-03
DE69113221T2 (de) 1996-03-28
CA2064796A1 (en) 1991-12-30
DE69113221D1 (en) 1995-10-26
AU7955491A (en) 1992-01-23

Similar Documents

Publication Publication Date Title
ATE128128T1 (de) Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
ATE158288T1 (de) Antiatherosklerotische und antithrombotische 1- benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on- derivate
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200001224A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
ATE337316T1 (de) Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen
ATE253063T1 (de) 5-ht1f-agonisten
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DK0682664T3 (da) Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler
FI831230L (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
DE3887151D1 (de) Inhibitoren für zellenzuwachs und methoden für krebsbehandlung.
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ATE173625T1 (de) Zusammensetzungen zur behandlung von hiv- infektionen
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
ES491960A0 (es) Procedimiento para la obtencion de derivados de sisomicina
ES2169022T3 (es) Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.
ID25478A (id) Agonis 5-ht1f
BG98238A (bg) Заместени бензотиазолови производни,получаванетоим и приложението им като хербициди
DK0758312T3 (da) Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler
DK398483A (da) Substituerede tert.butanol-derivater, fremgangsmaader til fremstilling deraf samt antimykotiske midler indeholdende disse forbindelser
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
EA200100152A1 (ru) Замещенные пиперазиноны и их терапевтическое применение

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee